Fluvirin
FDA Approves Vaccines for the 2011-2012 Influenza Season »
"The U.S. Food and Drug Administration announced today that it has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the six manufacturers licensed to produce and distribute influenza vaccine for the United "...
Read the FDA Approves Vaccines for the 2011-2012 Influenza Season article »
Fluvirin
PATIENT INFORMATION
Vaccine recipients and guardians should be informed by their health care provider of the potential benefits and risks of immunization with FLUVIRIN®. When educating vaccine recipients and guardians regarding the potential side effects, clinicians should emphasize that (1) FLUVIRIN® contains non-infectious particles and cannot cause influenza and (2) FLUVIRIN® is intended to provide protection against illness due to influenza viruses only, and cannot provide protection against all respiratory illness.
Vaccine recipients and guardians should be instructed to report any severe or unusual adverse reactions to their healthcare provider.
Vaccine recipients and guardians should be instructed that annual vaccination is recommended.
Last reviewed on RxList: 1/10/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Fluvirin Information
Fluvirin - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Living Better
Find the secrets to longer life.






